Non Invasive Monitoring Systems (NIMU) Liabilities and Shareholders Equity (2011 - 2025)
Non Invasive Monitoring Systems' (NIMU) quarterly Liabilities and Shareholders Equity came in at $6000.0 in Q4 2025, down 84.21% YoY from $38000.0 in Q4 2024, and down 14.29% on a QoQ basis from $7000.0 in Q3 2025.
Non Invasive Monitoring Systems (NIMU) Liabilities and Shareholders Equity (2011 - 2025) Analysis & Trends
Non Invasive Monitoring Systems (NIMU) has 15 years of Liabilities and Shareholders Equity data on file, last reported at $6000.0 in Q4 2025.
- Quarterly Liabilities and Shareholders Equity fell 84.21% year-over-year to $6000.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $81000.0 (down 67.98% YoY) and the FY2025 annual result came in at $7000.0, down 79.41% from the prior year.
- Liabilities and Shareholders Equity eased to $6000.0 in Q4 2025, from $7000.0 in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $183000.0 in Q4 2023 to a low of $6000.0 in Q4 2025.
- A 5-year average of $68700.0 and a median of $66500.0 in 2021 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity jumped 73.91% — and 2025, when it plunged 84.21%.
- Tracing NIMU's Liabilities and Shareholders Equity over 5 years: stood at $135000.0 in 2021, then slipped by 5.19% to $128000.0 in 2022, then jumped by 42.97% to $183000.0 in 2023, then sank by 79.23% to $38000.0 in 2024, then sank by 84.21% to $6000.0 in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $6000.0 (Q4 2025), $7000.0 (Q3 2025), and $25000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 261.48 Mn |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 245.80 Mn |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 514.10 Mn |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 464.99 Mn |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 98.35 Mn |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 247.73 Mn |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 314.37 Mn |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 374.60 Mn |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 376.80 Mn |
| 10 | Non Invasive Monitoring Systems | 1.43 Mn | 1.43 Mn | - | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 6,000.00 |
| Jul 31, 2025 | 7,000.00 |
| Apr 30, 2025 | 25,000.00 |
| Jan 31, 2025 | 43,000.00 |
| Oct 31, 2024 | 38,000.00 |
| Jul 31, 2024 | 34,000.00 |
| Apr 30, 2024 | 80,000.00 |
| Jan 31, 2024 | 101,000.00 |
| Oct 31, 2023 | 183,000.00 |
| Jul 31, 2023 | 23,000.00 |
| Apr 30, 2023 | 46,000.00 |
| Jan 31, 2023 | 77,000.00 |
| Oct 31, 2022 | 128,000.00 |
| Jul 31, 2022 | 21,000.00 |
| Apr 30, 2022 | 74,000.00 |
| Jan 31, 2022 | 103,000.00 |
| Oct 31, 2021 | 135,000.00 |
| Jul 31, 2021 | 59,000.00 |
| Apr 30, 2021 | 76,000.00 |
| Jan 31, 2021 | 115,000.00 |